You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

208 search results for: type 2 inflammation

<b>Type</b> <b>2</b> <b>Inflammation</b> Underpins Pediatric Severe Asthma

Infographic

Type 2 Inflammation Underpins Pediatric Severe Asthma

5 min

Pulmonology

Learn about the role type 2 inflammation plays in the burden and pathophysiology of severe asthma in pediatric patients.

The Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Chronic Spontaneous Urticaria (CSU)

Infographic

The Role of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU)

5 min

Dermatology

A summary infographic capturing how type 2 inflammation contributes to pathological processes leading to CSU signs and symptoms.

expert video

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

15 min

Dermatology

In this ADVENT symposium at the 2024 EADV meeting, Professor Enno Schmidt discusses the pathophysiology of BP, focusing on autoimmunity and the role of type 2 inflammation.

<b>Type</b> <b>2</b> <b>Inflammation</b> Digital Assessment Tool

interactivity

Type 2 Inflammation Digital Assessment Tool

4 min

Pulmonology

Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.

The Prevalence and Burden of <b>Type</b> <b>2</b> <b>Inflammation</b> in Patients With CRSwNP

expert video

The Prevalence and Burden of Type 2 Inflammation in Patients With CRSwNP

8 min

Rhinology

Dr. Stella Lee educates on the immune responses mediating CRSwNP and the prevalence of type 2 inflammation.

IFOS <b>2</b>0<b>2</b>3 | <b>Type</b> <b>2</b> <b>Inflammation</b> and Clinically Relevant Improvements in CRSwNP

expert video

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

42 min

Rhinology

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

UCARE <b>2</b>0<b>2</b>3: Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in CSU Pathogenesis

expert video

UCARE 2023: Role of Type 2 Inflammation in CSU Pathogenesis

7 min

Dermatology

Dr. Saini provides a deep dive into the pathophysiology of type 2 inflammation in CSU.

The Pathophysiology of <b>Type</b> <b>2</b> <b>Inflammation</b> in CRSwNP

interactivity

The Pathophysiology of Type 2 Inflammation in CRSwNP

5 min

Rhinology

Learn how type 2 inflammation underlies the pathophysiology of CRSwNP

Connecting <b>Type</b> <b>2</b> <b>Inflammation</b> to CRSwNP

expert video

Connecting Type 2 Inflammation to CRSwNP

1 min

Rhinology

Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.

<b>Type</b> <b>2</b> <b>Inflammation</b> Mediates Severe Asthma in Pediatric Patients

expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

19 min

Pulmonology

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

Blisters and Beyond: Autoimmunity Meets <b>Type</b> <b>2</b> <b>Inflammation</b> in Bullous Pemphigoid

expert video

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

12 min

Dermatology

Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms

<b>Type</b> <b>2</b> <b>Inflammation</b> Is a Significant Driver of Pediatric Severe Asthma

Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

5 min

Pulmonology

Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChinaChange country/region